SCHEMBL23745504

SCHEMBL23745504

Cc1cccc(C(CC(=O)N(C)C2CCNCC2)c2cn(CC3CCCCC3)c3ccccc23)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 6/20 0.40
KMT2A Q03164 2/20 0.39
CCR5 P51681 2/20 0.36
MGAM O43451 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
ICMT O60725 1/20 0.36
MAPT P10636 1/20 0.36
ALDH1A1 P00352 1/20 0.35
CNR2 P34972 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
CHRM1 P11229 1/20 0.35
TPSAB1 Q15661 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23745696 0.91 CNR1 (0.37) CNR1KMT2ACCR5ICMTCNR2
SCHEMBL23745802 0.85 CNR1 (0.42) CNR1KMT2AICMTMAPTALDH1A1
SCHEMBL22439066 0.85 CNR1 (0.47) CNR1MGAMGAASIMGAM2
Hydrochloric Acid SCHEMBL23722145 0.84 CNR1 (0.41) CNR1KMT2AICMTMAPTALDH1A1
SCHEMBL23745461 0.84 CNR1 (0.41) CNR1KMT2AMGAMGAASI
Hydrochloric Acid SCHEMBL23722020 0.83 CNR1 (0.40) CNR1KMT2AMGAMGAASI
SCHEMBL23745536 0.83 ICMT (0.47) CNR1MGAMGAASIMGAM2
SCHEMBL23745824 0.83 CNR1 (0.42) CNR1KMT2AMGAMGAASI
SCHEMBL22439554 0.82 CNR1 (0.43) CNR1MGAMGAASIMGAM2
Hydrochloric Acid SCHEMBL23722177 0.82 ICMT (0.46) CNR1MGAMGAASIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF BIOIMICS AB (SE) 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF FDPS, FPR1, F12 CNR1 1651/4885KMT2A 4684/4885CCR5 373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.